Federal Register Notices > Importers Notice of Registration - 2012 > Almac Clinical Services, Inc.
Information and Legal Resources Banner

Notice of Registration - 2012


[Federal Register Volume 77, Number 161 (Monday, August 20, 2012)]
[Notices]
[Pages 50162-50163]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20370]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances; Notice of Registration; Almac Clinical Services, Inc.

By Notice dated April 17, 2012, and published in the Federal Register on April 26, 2012, 77 FR 24985, Almac Clinical Services, Inc., (ACSI), 25 Fretz Road, Souderton, Pennsylvania 18964, made application
by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances:

Drug Schedule
Oxycodone (9143) II
Hydromorphone (9150) II
Tapentadol (9780) II
Fentanyl (9801) II

The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Almac Clinical Services, Inc. (ACSI) to import the
basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has
investigated Almac Clinical Services, Inc. (ACSI) to ensure that the company's registration is consistent with the public interest.

The investigation has included inspection and testing of the company's

[[Page 50163]]

physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.

Dated: August 7, 2012.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2012-20370 Filed 8-17-12; 8:45 am]
BILLING CODE 4410-09-P


 

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).

DEA: Drug Enforcement Administration Home